HealthEquity's High-Margin HSA Assets: Analyst's Perspective On Their Impact On Revenue
Portfolio Pulse from Nabaparna Bhattacharya
KeyBanc Capital Markets analyst Scott Schoenhaus reiterated an Overweight rating on HealthEquity, Inc. (NASDAQ:HQY) with a price target of $85. The analyst is bullish on the company's higher custodial yields and expects revenue growth through market share gains in the Health Savings Accounts markets. FY24 and FY25 revenue and adj. EBITDA estimates have been increased.
June 12, 2023 | 6:39 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
KeyBanc analyst Scott Schoenhaus reiterated an Overweight rating on HealthEquity with a price target of $85, citing higher custodial yields and potential market share gains in the Health Savings Accounts markets.
The analyst's bullish stance on HealthEquity's higher custodial yields and potential market share gains in the Health Savings Accounts markets, along with increased revenue and adj. EBITDA estimates for FY24 and FY25, suggest a positive short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100